- Home
- APCX vs PYPD Comparison
APCX vs PYPD Comparison
Compare APCX & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APCX
- PYPD
- Stock Information
- Founded
- APCX 2006
- PYPD 2008
- Country
- APCX United States
- PYPD Israel
- Employees
- APCX N/A
- PYPD N/A
- Industry
- APCX Finance: Consumer Services
- PYPD Medical/Dental Instruments
- Sector
- APCX Finance
- PYPD Health Care
- Exchange
- APCX Nasdaq
- PYPD Nasdaq
- Market Cap
- APCX N/A
- PYPD 19.4M
- IPO Year
- APCX N/A
- PYPD 2020
- Fundamental
- Price
- APCX $0.69
- PYPD $2.94
- Analyst Decision
- APCX
- PYPD Strong Buy
- Analyst Count
- APCX 0
- PYPD 2
- Target Price
- APCX N/A
- PYPD $10.50
- AVG Volume (30 Days)
- APCX 11.2M
- PYPD 43.8K
- Earning Date
- APCX 11-14-2024
- PYPD 02-12-2025
- Dividend Yield
- APCX N/A
- PYPD N/A
- EPS Growth
- APCX N/A
- PYPD N/A
- EPS
- APCX N/A
- PYPD N/A
- Revenue
- APCX $365,000.00
- PYPD N/A
- Revenue This Year
- APCX $1,315.48
- PYPD N/A
- Revenue Next Year
- APCX N/A
- PYPD N/A
- P/E Ratio
- APCX N/A
- PYPD N/A
- Revenue Growth
- APCX N/A
- PYPD N/A
- 52 Week Low
- APCX $0.31
- PYPD $2.37
- 52 Week High
- APCX $2.30
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- APCX 57.22
- PYPD 44.37
- Support Level
- APCX $0.65
- PYPD $2.60
- Resistance Level
- APCX $0.91
- PYPD $3.85
- Average True Range (ATR)
- APCX 0.18
- PYPD 0.38
- MACD
- APCX 0.04
- PYPD 0.01
- Stochastic Oscillator
- APCX 31.36
- PYPD 27.03
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.